Short Story
DACH Biotech (Chandigarh) is building an affordable, rapid prostate cancer diagnostic kit for point-of-care use—empowering early detection in low-resource settings and accelerating oncology access.
DACH Biotech Pvt Ltd
-
₹3,999,998.00
Funding Goal -
₹0.00
Funds Raised -
0
Days to go -
Target Goal
Campaign End Method
Campaign Story
DACH Biotech Pvt. Ltd., recently incorporated in February 2025 in Chandigarh, is pioneering affordable and scalable healthcare innovation with its rapid prostate cancer detection kit. Leveraging a multiplex diagnostic approach, the kit targets critical early biomarkers (KLK2/3/4), enabling non-invasive, point-of-care screening in rural and underserved settings. Designed for ease of use and cost-effectiveness, it empowers early detection and inclusion of prostate health in primary care. Named among the five DeepTech startups launched under Panjab University’s CIIPP-DST TEC incubator, DACH Biotech received funding support (₹3 lakh) at its unveiling—validating its potential to transform oncology screening in India’s diagnostics landscapeÂ
-
Sector: Point-of-care diagnostics / Medical Devices
-
Location: Chandigarh, India (House No. 198, Sector 38A, Chandigarh)
-
Founders / Directors: Dr. Merry Chaterji, Kirti
-
Product Focus: Rapid prostate cancer detection kit targeting early-stage screening in low-resource areas
-
Public Email: Not available publicly; contact may be facilitated via Panjab University or registrars.
Reviews
There are no reviews yet.